Skip to main content

Stellantis announces Windsor Assembly Plant to produce full-size vehicles from Brampton

The Windsor Assembly Plant in Windsor, Ont., on Wednesday, May 20, 2020. (Bob Bellacicco / CTV Windsor) The Windsor Assembly Plant in Windsor, Ont., on Wednesday, May 20, 2020. (Bob Bellacicco / CTV Windsor)
Share

Vehicles produced on the new STLA Large platform will be built at the Windsor Assembly Plant, according to an announcement from Stellantis on Friday.

Production of the current L-series vehicles – Chrysler 300, Dodge Charger, Dodge Challenger – at the Brampton Assembly Plant will end when retooling begins in 2024, as announced on May 2. A product announcement for Brampton will be made at a later date.

The moves are part of the company’s $3.6-billion investment to support its Dare Forward 2030 strategic plan and its long-term electrification strategy to invest $45 billion through 2025 in electrification and software globally.

“There has been a lot of speculation, and while we’re not prepared to discuss any product details today, we’re happy to confirm that Windsor will produce vehicles on our new STLA Large platform,” said Mark Stewart, Stellantis North America COO. “These announcements represent key pieces of our Dare Forward strategy to provide safe, clean and affordable mobility solutions for our customers long into the future.”

As part of the investment announced in May, the Windsor Assembly Plant will be transformed to support battery-electric vehicle (BEV) capability for multiple models.

“The plant will have maximum flexibility to adjust production volumes as needed to meet changing market demand over the next decade,” according to a Stellantis news release.

Retooling is expected to begin in 2023.

The company said it is also committed to retooling and modernizing the Brampton Assembly Plant beginning in 2024. When production resumes in 2025, the plant will introduce an all-new, flexible architecture to support the company’s electrification plans.

CTVNews.ca Top Stories

Trump chooses anti-vaccine activist Robert F. Kennedy Jr. as health secretary

President-elect Donald Trump announced Thursday he will nominate anti-vaccine activist Robert F. Kennedy Jr. to lead the Department of Health and Human Services, putting a man whose views public health officials have decried as dangerous in charge of a massive agency that oversees everything from drug, vaccine and food safety to medical research, Medicare and Medicaid.

Centre Block renovation facing timeline and budget 'pressures'

The multi-billion-dollar renovation of parliament’s Centre Block building continues to be on time and on budget, but construction crews are facing 'pressures' when it comes to the deadline and total costs, according to the department in charge of the project.

Measles cases in New Brunswick continue to climb

The number of measles cases in New Brunswick continue to climb. Officials with New Brunswick’s Department of Health said as of Thursday, the number of confirmed cases since October has reached 43.

Stay Connected